Status | Study |
Recruiting |
Study Name: Myeloproliferative Neoplasms (MPNs) Patient Registry Condition: Primary Myelofibrosis Polycythemia Vera Essential Thromboc Date: 2016-03-24 Interventions: Other: Observational |
Recruiting |
Study Name: Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT Condition: Leukemia, Chronic Myeloid Myelodysplastic Syndromes Date: 2015-12-04 Interventions: Procedure: Unrelated allogeneic stem cell transplantation |
Withdrawn |
Study Name: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) Condition: Chronic Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia Date: 2015-09-29 Interventions: Drug: Pacritinib -Patients sho |
Completed |
Study Name: Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders Condition: Accelerated Phase of Disease Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Date: 2014-08-05 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia Condition: Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Neutrophilic Leukemia Date: 2014-03-18 Interventions: Other: Laboratory Biomarker Analysis |
Withdrawn |
Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-03-16 Interventions: Procedure: management of therapy complications |
Completed |
Study Name: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Condition: Adult Acute Lymphoblastic Leukemia Adult Acute Myeloid Leukemia Date: 2011-10-21 Interventions: Drug: cefepime hydrochloride Given IV Other Names: |
Completed |
Study Name: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-11-02 Interventions: Biological: palifermin Given I |
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Leukemias of Ambiguous Lineage Date: 2010-10-29 Interventions: Drug: Akt inhibitor MK2206 Giv |
Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition: Hematopoietic/Lymphoid Cancer Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-09-08 Interventions: Procedure: infection prophylaxis and management |